provider of an integrated hardware and software platform digitizing microbiology experiments
Reshape Biotech has raised €26M across 2 funding rounds from 9 investors, most recently a Series A round in Apr 2024. Based in Copenhagen, Denmark; active in Software. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-04-09 | Series A | €18M | 21stBio,ACME Capital,Astanor Ventures,Nicholas Francis,R7,YC | View deal → |
| 2023-02-09 | Other | €7.5M | ACME Capital,FundersClub,Nicholas Francis,Per Falholt,Y Combinator | View deal → |
